1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Lymphoma, Large B-Cell, Diffuse

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Lymphoma, Large B-Cell, Diffuse in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aglietta, M; Arese, M; Barra, L; Benelli, R; Bussolino, F; Ghigo, D; Montrucchio, G; Primo, L; Rola-Pleszczynski, MR; Sanavio, F	1
Fernandez-Gallardo, S; Garcia, C; Garcia, MC; Gijon, MA; Mollinedo, F; Sanchez Crespo, M	1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Lymphoma, Large B-Cell, Diffuse

Article	Year
Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. The Journal of clinical investigation, 1995, Volume: 96, Issue:2 Topics: Aged; Animals; Azepines; Base Sequence; Cell Line; Chemotaxis; Choriocarcinoma; Collagen; Culture Media, Conditioned; Cytokines; Dogs; Drug Combinations; Endothelium, Vascular; Female; Growth Substances; Humans; Interleukin-1; Laminin; Lymphoma, Large B-Cell, Diffuse; Macrophages; Male; Mice; Mice, Inbred DBA; Molecular Sequence Data; Neoplasm Proteins; Neovascularization, Pathologic; Platelet Activating Factor; Platelet Membrane Glycoproteins; Proteoglycans; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sarcoma, Kaposi; Skin Neoplasms; Thrombin; Triazoles; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Umbilical Veins; Uterine Neoplasms	1995
Metabolism of platelet-activating factor in human haematopoietic cell lines. Differences between myeloid and lymphoid cells. The Biochemical journal, 1991, Feb-01, Volume: 273 ( Pt 3) Topics: Acetates; Acetyltransferases; B-Lymphocytes; Burkitt Lymphoma; Cell Differentiation; Cell Line; Cell Membrane; Humans; Kinetics; Lymphoma, Large B-Cell, Diffuse; Phospholipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sulfuric Acid Esters; T-Lymphocytes; Temperature; Tetradecanoylphorbol Acetate	1991

Article

Year

Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.

The Journal of clinical investigation, 1995, Volume: 96, Issue:2

Topics: Aged; Animals; Azepines; Base Sequence; Cell Line; Chemotaxis; Choriocarcinoma; Collagen; Culture Media, Conditioned; Cytokines; Dogs; Drug Combinations; Endothelium, Vascular; Female; Growth Substances; Humans; Interleukin-1; Laminin; Lymphoma, Large B-Cell, Diffuse; Macrophages; Male; Mice; Mice, Inbred DBA; Molecular Sequence Data; Neoplasm Proteins; Neovascularization, Pathologic; Platelet Activating Factor; Platelet Membrane Glycoproteins; Proteoglycans; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sarcoma, Kaposi; Skin Neoplasms; Thrombin; Triazoles; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Umbilical Veins; Uterine Neoplasms

1995

Metabolism of platelet-activating factor in human haematopoietic cell lines. Differences between myeloid and lymphoid cells.

The Biochemical journal, 1991, Feb-01, Volume: 273 ( Pt 3)

Topics: Acetates; Acetyltransferases; B-Lymphocytes; Burkitt Lymphoma; Cell Differentiation; Cell Line; Cell Membrane; Humans; Kinetics; Lymphoma, Large B-Cell, Diffuse; Phospholipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sulfuric Acid Esters; T-Lymphocytes; Temperature; Tetradecanoylphorbol Acetate

1991